Multi-omics analysis identifies stemness-driven molecular subtypes, prognostic signature, epigenetic target APCDD1, and drug candidate Leflunomide in Wilms tumor - Quiz - MDSpire

Multi-omics analysis identifies stemness-driven molecular subtypes, prognostic signature, epigenetic target APCDD1, and drug candidate Leflunomide in Wilms tumor

  • By

  • Huifang Du

  • Yifeng Zheng

  • Chentao Zhu

  • Yang Guo

  • Pengfei Li

  • Peng Hong

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Multi-omics analysis identifies stemness-driven molecular subtypes, prognostic signature, epigenetic target APCDD1, and drug candidate Leflunomide in Wilms tumor

  • by Huifang Du, Yifeng Zheng, Chentao Zhu, Yang Guo, Pengfei Li, Peng Hong

  • May 25, 2026

Related Content

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation